Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Bucher

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
BMC Cancer|October 17, 2014
Chemically induced mouse liver tumors are resistant to treatment with atorvastatinAlbert Braeuning, Philip Bucher, Ute Hofmann, et al.
Biomedicines|March 29, 2018
NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted TherapyPaula Grondona, Philip Bucher, Klaus Schulze-Osthoff, et al.
BMC Bioinformatics|April 14, 2007
Splicy: a web-based tool for the prediction of possible alternative splicing events from Affymetrix probeset dataDavide Rambaldi, Barbara Felice, Viviane Praz, et al.
JCI Insight|October 18, 2019
Keratinocyte-derived IκBζ drives psoriasis and associated systemic inflammationSebastian Lorscheid, Anne Müller, Jessica Löffler, et al.
The Journal of Investigative Dermatology|February 10, 2020
Threonine Phosphorylation of IκBζ Mediates Inhibition of Selective Proinflammatory Target GenesPaula Grondona, Philip Bucher, Anja Schmitt, et al.
Theranostics|February 16, 2026
Modeling immunotherapies in live 3D human cancer tissue bioreactorsYizheng Zhang, Ivan Foth, Ahmad Makky, et al.
Nature Communications|June 6, 2022
Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptorValentina Scabia, Ayyakkannu Ayyanan, Fabio De Martino, et al.
Blood|December 4, 2019
Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphomaPhilip Bucher, Tabea Erdmann, Paula Grondona, et al.
Blood Advances|November 7, 2023
Inhibition of glutaminase-1 in DLBCL potentiates venetoclax-induced antitumor activity by promoting oxidative stressBeatriz Gomez Solsona, Heike Horn, Anja Schmitt, et al.
Cancer Discovery|February 26, 2026
Integrated chronic in vivo and in vitro screens uncover NFIL3 as a driver of T cell dysfunctionNayan Jain, Yuzhe Shi, Celina May, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BMC Cancer|October 17, 2014
Chemically induced mouse liver tumors are resistant to treatment with atorvastatinAlbert Braeuning, Philip Bucher, Ute Hofmann, et al.
Biomedicines|March 29, 2018
NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted TherapyPaula Grondona, Philip Bucher, Klaus Schulze-Osthoff, et al.
BMC Bioinformatics|April 14, 2007
Splicy: a web-based tool for the prediction of possible alternative splicing events from Affymetrix probeset dataDavide Rambaldi, Barbara Felice, Viviane Praz, et al.
JCI Insight|October 18, 2019
Keratinocyte-derived IκBζ drives psoriasis and associated systemic inflammationSebastian Lorscheid, Anne Müller, Jessica Löffler, et al.
The Journal of Investigative Dermatology|February 10, 2020
Threonine Phosphorylation of IκBζ Mediates Inhibition of Selective Proinflammatory Target GenesPaula Grondona, Philip Bucher, Anja Schmitt, et al.
Theranostics|February 16, 2026
Modeling immunotherapies in live 3D human cancer tissue bioreactorsYizheng Zhang, Ivan Foth, Ahmad Makky, et al.
Nature Communications|June 6, 2022
Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptorValentina Scabia, Ayyakkannu Ayyanan, Fabio De Martino, et al.
Blood|December 4, 2019
Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphomaPhilip Bucher, Tabea Erdmann, Paula Grondona, et al.
Blood Advances|November 7, 2023
Inhibition of glutaminase-1 in DLBCL potentiates venetoclax-induced antitumor activity by promoting oxidative stressBeatriz Gomez Solsona, Heike Horn, Anja Schmitt, et al.
Cancer Discovery|February 26, 2026
Integrated chronic in vivo and in vitro screens uncover NFIL3 as a driver of T cell dysfunctionNayan Jain, Yuzhe Shi, Celina May, et al.
Pageof 2